1. A phase 3, randomized study of ofatumumab combined with bendamustine in rituximab‐refractory iNHL (COMPLEMENT A + B study). (10th May 2021) Authors: Rummel, Mathias J.; Janssens, Ann; MacDonald, David; Keating, Mary‐Margaret; Zaucha, Jan M.; Davis, Jaclyn; Lasher, Janet; Babanrao Pisal, Chaitali; Izquierdo, Miguel; Friedberg, Jonathan W. Journal: British journal of haematology Issue: Volume 193:Number 6(2021) Page Start: 1123 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗